Avanir Pharmaceuticals Inc. (AVNR.OB) Moves Forward with Zenvia Product, Pays Down Debt through $40 Million Equity Offering
The two critical elements to watch in the pharmaceutical industry are product development and FDA approvals. If a company’s product development pipeline starts to get a bit thin, it will eventually lose revenue generating capacity as patents expire and competition moves in. If FDA approval isn’t obtained, the company is simply sunk in the US for that product. As an investor, watching the product pipeline is the key. This is important not only for the company’s current and future profitability, but because other companies, which may not have the same product development strength, may become interested in acquiring it. In…